Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

733 ARTÍCULOS , VIENDO DEL 271 AL 285

Microbiome-Phytochemical Crosstalk Along the Gut-Brain Axis in Alzheimer and Parkinson's Disease

Emon M, Rahaman MM, Sarder D, Shadin M, Neela SA, Wangchuk P, Sarker S.

Microbiologyopen. 2026 Aug;15(4):e70374. doi: 10.1002/mbo3.70374.

Tau dysfunction in alzheimer's disease: molecular and cellular mechanisms, genetic modulation, and therapeutic perspectives

Sura S, Jagadeesan S, Moklas MAM, Masrudin SS, Dandala KCR, Judson JP, MohdNor NH.

Mol Biol Rep. 2026 Aug 13;53(1):1396. doi: 10.1007/s11033-026-12578-0.

Peroxynitrite: A potential therapeutic target for Alzheimer's disease

Liu WZ, Piao ZJ, Zhu TL, Lim V, Ooi JP, Niu QQ.

Ageing Res Rev. 2026 Oct;121:103299. doi: 10.1016/j.arr.2026.103299. Epub 2026 Aug 13.

Volume change with gantenerumab: Impact of amyloid-related imaging abnormalities and amyloid removal

Tonietto M, Silvestri E, Belder CRS, Barkhof F, Fox NC, Smith J, Klein G.

Alzheimers Dement. 2026 Aug;22(8):e71749. doi: 10.1002/alz.71749.

Active Vaccination Strategies for Alzheimer's Disease: An Expanded Review

Comitato A, Neri A, Cossarizza A.

Eur J Immunol. 2026 Aug;56(8):e70250. doi: 10.1002/eji.70250.

Longitudinal effects of physical activity on sleep in association with hippocampal-amygdala subfield structure and functional connectivity in Alzheimer's disease

Dadsena R, Costa AS, David S, Haberl L, Schulz JB, Reetz K, Haeger A.

Alzheimers Dement. 2026 Aug;22(8):e71651. doi: 10.1002/alz.71651.

APOE-guided lecanemab dosing dissociates ARIA-E from ARIA-H: The K-ROAD study

Kang H, Jang H, Ahn J, Na DL, Lee JH, Kim EJ, Chun MY, Cho SH, Kim BC, Kim SE, Sohn G, Yun J, Lee JS, Park KC, Park HK, Kim YJ, Lee K, Yim S, Kim S, Kim JP, Kim HJ, Lim JS, Seo SW.

Alzheimers Dement. 2026 Aug;22(8):e71765. doi: 10.1002/alz.71765.

The potential connection between inflammatory bowel disease and Alzheimer's disease: mechanistic insights and therapeutic implications

Peng L, Wu Z, Yuan X, Zhou C, Fu H.

Front Immunol. 2026 Aug 7;17:1910604. doi: 10.3389/fimmu.2026.1910604. eCollection 2026.

Amyloid-related imaging abnormalities in Japanese patients with Alzheimer's disease treated with Lecanemab: A real-world study

Shimasaki R, Kurihara M, Bannai T, Hatano K, Suzuki F, Tokumaru AM, Ishii K, Ihara R, Iwata A.

J Prev Alzheimers Dis. 2026 Jun;13(6):100562. doi: 10.1016/j.tjpad.2026.100562. Epub 2026 Apr 4.

Multicomponent Behavior Change Technique Intervention for Caregivers of People With Alzheimer Disease and Related Dementias: Protocol for a Single-Arm, Personalized Behavioral Trial to Disrupt Sedentary Time

Miller D, Lambert S, Jordan L, Butler MJ, Sinvani L, Perrin A, Cheung YK, Davidson KW, Goodwin AM.

JMIR Res Protoc. 2026 Jun 9;15:e82857. doi: 10.2196/82857.

Cerebral hypoperfusion and the vascular-metabolic-immune-glymphatic network in Alzheimer's disease: mechanisms, diagnosis, and therapy

Yao M, Liu A, Song J, Xing L, Zi M, Li H.

Neuroscience. 2026 Aug 28;610:163-188. doi: 10.1016/j.neuroscience.2026.06.001. Epub 2026 Jun 10.

Donanemab treatment effect by baseline tau burden and disease severity: Observations from the TRAILBLAZER-ALZ 2 trial

Raket LL, Lu M, Evans CD, Zimmer JA, Sparks J, Collins EC, Shcherbinin S, Wang H, Nery ESM, Epelbaum S, Dell'Agnello G, Brooks DA, Sims JR, Mintun MA.

Alzheimers Dement. 2026 Jun;22(6):e71577. doi: 10.1002/alz.71577.

Amyloid-Related Imaging Abnormalities in Anti-amyloid Therapy: Clinical Implications of Kinetics for Safer Use and Risk Stratification

Totuk O.

Clin Drug Investig. 2026 Aug;46(8):803-808. doi: 10.1007/s40261-026-01572-w. Epub 2026 Jun 12.

NegotiAge-An AI-Based Caregiver Negotiation Training: Results From the Multiphase Optimization Strategy (MOST) Trial

Ramirez-Zohfeld V, Murawski A, Jobin C, Olvera C, Mell J, Brett J, Gratch J, Tschoe M, Pfammatter AF, Lindquist LA.

J Am Geriatr Soc. 2026 Jul;74(7):2032-2040. doi: 10.1111/jgs.70546. Epub 2026 Jun 17.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias